Heramed Limited (ASX:HMD)

20.0¢

right-arrow Created with Sketch. -0.01 (-4.76%)
MCAP $37.64M
Last trade 15.55pm 28/01/2022 20mins delayed

Latest Announcements

28/01/2022HMDHeramed Limited
133
MCap
28/01/2022HMDHeramed Limited
21/01/2022 Price SensitivePSHMDHeramed Limited
21/01/2022 Price SensitivePSHMDHeramed Limited
20/01/2022 Price SensitivePSHMDHeramed Limited
18/01/2022 Price SensitivePSHMDHeramed Limited
9,049
MCap
18/01/2022 Price SensitivePSHMDHeramed Limited
1,670
MCap
20/12/2021HMDHeramed Limited

Company Overview

Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

HMD in the news

Digital maternity care company HeraMED (HMD) has hit a “truly significant milestone”…
Medical tech company HeraMED (HMD) raises roughly $2.39 million through a convertible…
Pregnancy technology company HeraMED (HMD) receives interim results from its paid pilot…

Search Previous Announcements